Christina Kay serves as Executive at INTEGRATED BIOPHARMA INC, where they oversee executive responsibilities. Since joining the company, Christina Kay has executed 11 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 20, 2023 involved receiving (via award) 50,000 shares valued at $4.5K.
Christina Kay currently holds 1,273,467 shares of INTEGRATED BIOPHARMA INC (INBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christina Kay has been a net neutral trader of INBP stock. They have purchased $0 and sold $0 worth of shares.
Christina Kay's most recent insider trade was on Sep 20, 2023, when they sold 50,000 shares at $0.09 per share.
Get notified when new Form 4 filings are submitted
| $0.34 |
| Discretionary |
| May 25, 2023 | INBP | $1.4M | Award | 3,410,512 | $0.40 | Discretionary |
| Dec 19, 2018 | INBP.OB | $7.0K | Award | 50,000 | $0.14 | Discretionary |
| Dec 19, 2018 | INBP.OB | $7.0K | Award | 50,000 | $0.14 | Discretionary |
| Aug 12, 2008 | INBP | $100.0K | Conversion | 66,666 | $1.50 | Discretionary |
| Aug 12, 2008 | INBP | $33.0K | Conversion | 100,000 | $0.33 | Discretionary |
| Aug 12, 2008 | INBP | $75.0K | Conversion | 150,000 | $0.50 | Discretionary |
| Aug 12, 2008 | INBP | $75.0K | Conversion | 100,000 | $0.75 | Discretionary |
| Nov 16, 2007 | INBP | $0 | Award | 70,000 | $N/A | Discretionary |
| Feb 7, 2007 | INBP | $231.2K | Award | 34,000 | $6.80 | Discretionary |